3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 25 0 1 0 0 0 0 0999 V2000
1.8756 -0.4098 0.4138 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0284 2.6093 0.0562 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1604 1.4124 -0.9710 O 0 0 0 0 0 0 0 0 0 0 0 0
0.2352 1.2866 0.5189 C 0 0 1 0 0 0 0 0 0 0 0 0
-0.9359 0.4142 0.2155 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9798 0.3038 1.1341 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9875 -0.2908 -0.9870 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5290 0.7989 -0.1198 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0752 -0.5118 0.8504 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0831 -1.1064 -1.2707 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0879 -0.9812 -0.0876 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1269 -1.2167 -0.3520 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3284 -2.3086 0.5992 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4161 1.3534 1.5982 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.9520 0.8494 2.0736 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.2005 -0.2133 -1.7316 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.8882 -0.5972 1.5653 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.1257 -1.6523 -2.2086 H 0 0 0 0 0 0 0 0 0 0 0 0
2.9988 -1.1347 -1.1688 H 0 0 0 0 0 0 0 0 0 0 0 0
3.9234 -0.3021 0.1160 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.9805 -1.8508 -0.5734 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.3427 2.5563 -0.8627 H 0 0 0 0 0 0 0 0 0 0 0 0
4.2494 -2.7747 0.2381 H 0 0 0 0 0 0 0 0 0 0 0 0
3.4017 -2.1738 1.6834 H 0 0 0 0 0 0 0 0 0 0 0 0
2.4920 -2.9921 0.4198 H 0 0 0 0 0 0 0 0 0 0 0 0
1 8 1 0 0 0 0
1 11 1 0 0 0 0
2 4 1 0 0 0 0
2 22 1 0 0 0 0
3 8 2 0 0 0 0
4 5 1 0 0 0 0
4 8 1 0 0 0 0
4 14 1 0 0 0 0
5 6 2 0 0 0 0
5 7 1 0 0 0 0
6 9 1 0 0 0 0
6 15 1 0 0 0 0
7 10 2 0 0 0 0
7 16 1 0 0 0 0
9 12 2 0 0 0 0
9 17 1 0 0 0 0
10 12 1 0 0 0 0
10 18 1 0 0 0 0
11 13 1 0 0 0 0
11 19 1 0 0 0 0
11 20 1 0 0 0 0
12 21 1 0 0 0 0
13 23 1 0 0 0 0
13 24 1 0 0 0 0
13 25 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
ethyl 2-hydroxy-2-phenylacetate
4.2 InChl
InChI=1S/C10H12O3/c1-2-13-10(12)9(11)8-6-4-3-5-7-8/h3-7,9,11H,2H2,1H3
4.3 InChlKey
SAXHIDRUJXPDOD-UHFFFAOYSA-N
4.4 Canonical SMILES
CCOC(=O)C(C1=CC=CC=C1)O
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病